REQUEST A DEMO
Total
USD $0.00
Search more companies

Vectura Fertin Pharma Laboratories Pte. Ltd. (Singapore)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Vectura Fertin Pharma Laboratories Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: research and experimental development on natural sciences n.e.c. (conduct research activities on development of reduced risk products)

Headquarters
50 Science Park Road, #02-07 The Kendall, Singapore
Singapore; Singapore; Postal Code: 117406

Contact Details: Purchase the Vectura Fertin Pharma Laboratories Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Vectura Fertin Pharma Laboratories Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Vectura Fertin Pharma Laboratories Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Vectura Fertin Pharma Laboratories Pte. Ltd. report to view the information.
Incorporation Date:
July 29, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Vectura Fertin Pharma Laboratories Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
13.74%
Total operating revenue
13.74%
Net Profit (Loss) for the Period
11.14%
Total assets
-23.84%
Total equity
75.19%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-25.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?